Pre-TACE CK-MB/CK Ratio as an Independent Prognostic Biomarker in Advanced Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma · 2026-09 · Volume 13 · 1-12
DOI: 10.2147/jhc.s621877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-09. Verfasst von Weiguo Lu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, People's…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, People's Republic of China.
- Department of Infectious Disease Prevention and Control, Guangzhou Center for Disease Control and Prevention (Guangzhou Health Inspection Institute), Guangzhou, Guangdong Province, People's Republic of China.
ORCID-Profile: Yang Wang
Zitieren
APA
Lu, W., Lu, Y., & Wang, Y. (2026). Pre-TACE CK-MB/CK Ratio as an Independent Prognostic Biomarker in Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, Volume 13, 1-12. https://doi.org/10.2147/jhc.s621877
Vancouver
Lu W, Lu Y, Wang Y. Pre-TACE CK-MB/CK Ratio as an Independent Prognostic Biomarker in Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-12. doi:10.2147/jhc.s621877
BibTeX
@article{Lu2026,
author = {Lu, Weiguo and Lu, Ying and Wang, Yang},
title = {Pre-TACE CK-MB/CK Ratio as an Independent Prognostic Biomarker in Advanced Hepatocellular Carcinoma},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--12},
doi = {10.2147/jhc.s621877}
}
EUVIMED